Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseControversies in the management of primary sclerosing cholangitisBrazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryPrimary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectivePathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementTreatment of autoimmune liver disease: current and future therapeutic options.A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.Therapeutic targeting of bile acidsPrimary sclerosing cholangitis: diagnosis, prognosis, and management.Overlap syndromes of autoimmune hepatitis: an open question.Primary sclerosing cholangitis: a review and update on therapeutic developments.Primary Sclerosing Cholangitis: Current and Future Management Strategies.Emerging treatments for primary sclerosing cholangitis.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?Cholestatic liver diseases: new targets, new therapiesPrimary sclerosing cholangitis: A review and update
P2860
Q22241416-3296238C-4326-452B-BD9C-29C1348BC26CQ26765804-705278BD-9F75-40EB-84FD-83D4A198AFB6Q26766699-CF4A5CDA-005B-47D8-B236-841829AE556EQ26771816-FA131794-0DC4-467B-A258-2E2D60CC8BC7Q26781780-33DC7C96-8FDC-49A0-830F-147999D1910BQ27015831-F08DC793-7DFF-4FAE-AB85-CB34113DDE94Q34342199-6AA47E8D-40D7-4C07-8825-877D6FC54704Q35778052-9EBA58B8-DCE3-4380-BF4C-E3DF70BFBF39Q35958534-20D8AB1F-99D5-477E-A43D-4B54FF47B94BQ36955053-834BB7FC-E960-43B4-A1E4-BFEF546B7B97Q38053908-83A6D1A0-70A0-4558-BEB2-630DEA46310CQ38077820-8A200A03-5DA1-46AE-A591-2712B999EE33Q38107484-618D8FB3-6C39-4BE7-BD2B-45A747A5A8EAQ38748384-BA73A6FE-707C-41E0-B2FE-3FFC5806BD4CQ38833243-FF6EB15E-FFFC-4A65-96A5-789543BD9746Q43585465-0CF20BDE-B4A4-47D4-80A8-2C698F7BCC79Q54939025-359403D4-5D01-4C9B-844B-7F554892A7A9Q57111104-9CC9E896-B817-4577-B691-8CB7940E6595Q57124621-2A031CC4-ECB7-49EB-B1D0-B6BE54159893
P2860
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@en
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@nl
type
label
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@en
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@nl
prefLabel
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@en
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@nl
P2093
P2860
P1476
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
@en
P2093
A K Burroughs
C K Triantos
N M Koukias
V N Nikolopoulou
P2860
P304
P356
10.1111/J.1365-2036.2011.04822.X
P407
P577
2011-08-22T00:00:00Z